Optical coherence tomography

Optical coherence tomography

NIDEK has released the upgraded unit of optical coherence tomography, RS-3000 Advance, with new features including 12 x 9mm wide area scan, tracing HD plus, torsion eye tracer and multi-functional follow-up. “The 12mm wide horizontal scan allows detailed observation of the vitreous body, retina and choroid from the macula to optic disc in a single image,” said a company spokesman. “The tracing HD plus function traces involuntary eye movements to maintain the same scan location on the SLO image for accurate image capture. The torsion eye tracer corrects ocular cyclotorsion and fundus tilt, and ensures accurate image capture. The multifunctional follow-up allows assessment of change over time combined with other examination results,” he said.

www.nidek.com

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...